logo
Tesla, Inc. (TSLA): 'I Would Neverrrr Sell Tesla In This,' Says Jim Cramer

Tesla, Inc. (TSLA): 'I Would Neverrrr Sell Tesla In This,' Says Jim Cramer

Yahoo14 hours ago

We recently published a list of . In this article, we are going to take a look at where Tesla, Inc. (NASDAQ:TSLA) stands against other stocks that Jim Cramer discusses.
Pixabay/Public Domain
Tesla, Inc. (NASDAQ:TSLA) is the world's largest pure-play electric vehicle manufacturer and a frequent feature of Cramer's morning show. Even though the firm's shares have been highly volatile in 2025, Cramer has been a believer most of the time. However, after frictions between Elon Musk and President Trump last week, Cramer took a cautious stance and wondered if holding on to Tesla, Inc. (NASDAQ:TSLA)'s shares was worth it. However, his latest discussion on Squawk on the Street saw him reverse the stance, much to the surprise of his co-hosts David Faber and Carl Quintanilla:
'We got a lot of downgrades and they, it physically stuck, it didn't go down and then it went up ten percent. I'll give you a good example. Guggenheim has a Sell on it today. If I crossed out the word Sell and read it, I would be buying. I mean it's that positive. It's about Robotaxi and it's about the total addressable market and initially Tesla won't do that well. But I've gotta tell you, I would neverrrr sell Tesla in this. And then Piper Sandler with just a few bullet points about why it's going to be fantastic. Driver-less Tesla's have been spotted in Austin. Of course he's walked back when it's going to be, but I continue to believe that you've got to own the stock.
While we acknowledge the potential of TSLA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
Inicia sesión para acceder a tu portafolio

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Your boss is probably using AI more than you
Your boss is probably using AI more than you

Yahoo

time31 minutes ago

  • Yahoo

Your boss is probably using AI more than you

Leaders use AI around twice as much as individual contributors, a new Gallup Poll finds. Gallup data indicates AI adoption has risen, especially in white-collar roles, with tech leading at 50%. 16% of employees surveyed who use AI "strongly agree" that AI tools provided by their company are useful. There's a good chance your boss is using AI more than you. Leaders are adopting AI at nearly double the rate of individual contributors, a new Gallup poll released Monday indicates. The survey found that 33% of leaders, or those who identified as "managers of managers," use AI frequently, meaning a few times a week or more, compared to 16% of individual contributors. Gallup's chief scientist for workplace management and wellbeing, Jim Harter, told Business Insider that leaders are likely feeling added pressure to think about AI and how it can increase efficiency and effectiveness. "There's probably more leaders experimenting with it because they see the urgency and they see it as a competitive threat potentially," Harter said. The data point was one of several findings from Gallup's survey on AI adoption in the workplace, including: The number of US employees who use AI at work at least a few times a year has increased from 21% to 40% in the past two years Frequent AI use increased from 11% to 19% since 2023 Daily use of AI doubled in the past year from 4% to 8% 15% of employees surveyed said it was "very or somewhat likely that automation, robots, or AI" would eliminate their jobs in a five-year period 44% of employees said their company has started to integrate AI, but only 22% say their company shared a plan or strategy 30% of employees said their company has "general guidelines or formal policies" in place for using AI at work 16% of the employees who use AI "strongly agree" that AI tools provided by their company are helpful for their job While AI adoption has increased overall in the last two years, that increase isn't evenly distributed across industries. The Gallup report said that AI adoption "increased primarily for white-collar roles," with 27% surveyed now saying they use AI frequently on the job, a 12% increase from last year. Among white-collar workers, frequent AI is most common in the tech industry, at 50%, according to the survey, followed by professional services at 34%, and finance at 32%. Meanwhile, frequent AI use among production and front-line workers has dropped from 11% in 2023 to 9% this year, according to Gallup's polling. Concerns that AI will eliminate jobs have also not increased overall in the last two years, but the report indicated that employees in industries like technology, retail, and finance are more likely than others to believe AI will one day take their jobs. The most common challenge with AI adoption, according to those surveyed, is "unclear use case or value proposition," suggesting that companies may not providing clear guidance. The report said that when employees say they "strongly agree" that leadership has shared a clear plan for using AI, they're three times as likely to feel "very prepared to work with AI" and 2.6 times as likely to feel comfortable using it at work. "In some cases, you've got to have the training to be able to use AI as a complement with other text analytic tools that are more precise," Gallup's Harter told BI. Harter said that while organizations are increasingly developing plans around AI usage, "there's still a long way to go," and it may not be a one-and-done approach. "They're going to have to continue to be trained in how to use it because it's going to evolve itself," Harter said. Read the original article on Business Insider

SINOVAC Board of Directors Alerts Shareholders to Advantech/Prime Success' New Lawsuit, Which Threatens to Prevent Payment of US$55.00 Special Dividend to All Valid Shareholders
SINOVAC Board of Directors Alerts Shareholders to Advantech/Prime Success' New Lawsuit, Which Threatens to Prevent Payment of US$55.00 Special Dividend to All Valid Shareholders

Business Wire

time34 minutes ago

  • Business Wire

SINOVAC Board of Directors Alerts Shareholders to Advantech/Prime Success' New Lawsuit, Which Threatens to Prevent Payment of US$55.00 Special Dividend to All Valid Shareholders

BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (' SINOVAC ' or the ' Company '), a leading provider of biopharmaceutical products in China, today disclosed that on June 12, 2025, Advantech/Prime Success filed a Petition for Emergency Injunctive Relief against SINOVAC, et al., naming as relief parties Cede & Co., The Depository Trust Company, and Equiniti (the dividend paying agent retained by the SINOVAC Board), which may prevent the SINOVAC Board from paying the US$55.00 special dividend as scheduled on or about July 9, 2025. We learned that Vivo Capital's counsel informed the paying agent that Vivo would challenge the dividend and asked the paying agent to withdraw from facilitating the distribution of the US$55.00 dividend declared by the SINOVAC Board to all valid shareholders. The SINOVAC Board has an obligation to answer this Petition on behalf of all SINOVAC common shareholders to stand up to the egregious actions of Prime Success. We expect to file our Opposition Brief today at 5:00 p.m. Atlantic Standard Time, followed by a hearing on Wednesday, June 18. We continue to be shocked by the self-serving, unnecessary actions by Advantech and Vivo Capital (together known as the 'Dissenting Investor Group') against SINOVAC, threatening the rightful dividend payment to all valid SINOVAC common shareholders. These incomprehensible actions are unacceptable to the SINOVAC Board because: The Dissenting Investor Group has already pocketed more than US$1.1 billion in dividends from SINOVAC's operating subsidiary, while all SINOVAC's valid shareholders received nothing. An amount equal to the aggregate amount of cash that would be payable under the US$55.00 per common share special dividend in respect of the 2018 PIPE shares has been set aside by the SINOVAC Board in an escrow account managed by an independent third party pending final resolution of the legal proceedings, which the Dissenting Investor Group initiated. Thus, there is no risk whatsoever that the Dissenting Investor Group's allocations of the dividend will not be paid if the courts ultimately decide in their favor regarding the PIPE shares. These new actions by the Dissenting Investor Group go against their assertions of their support of the US$55.00 dividend payment in their letters to shareholders and raises the question – how can you trust anything they say in their letters or press releases? The SINOVAC Board will continue to fight these frivolous lawsuits, all of which aim to accomplish one thing: to allow the Dissenting Investor group to double dip on dividends. We feel certain we will prevail quickly in this and other proceedings. The SINOVAC Board is on a mission to restore fairness and deliver value to ALL SINOVAC shareholders. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, etc. The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalification requirements in 2017. The EV71 vaccine, Inlive®, is an innovative vaccine under "Category 1 Preventative Biological Products" and commercialized in China in 2016. In 2022, SINOVAC's Sabin-strain inactivated polio vaccine (sIPV) and varicella vaccine were prequalified by the WHO. SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine, Panflu®, to the Chinese government stockpiling program. SINOVAC continually dedicates itself to new vaccine R&D, with more combination vaccine products in its pipeline, and constantly explores global market opportunities. SINOVAC plans to conduct more extensive and in-depth trade and cooperation with additional countries, and business and industry organizations. Safe Harbor Statement This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as 'may,' 'will,' 'expect,' 'anticipate,' 'aim,' 'estimate,' 'intend,' 'plan,' 'believe,' 'potential,' 'continue,' 'is/are likely to' or other similar expressions. Such statements are based upon current expectations and relate to events that involve known or unknown risks, uncertainties and other factors, including without limitation risks, uncertainties and factors related to the timing of filings, hearings and other litigation-related matters, all of which are difficult to predict and many of which are beyond the Company's control, which may cause actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

Asian shares are mixed and oil prices advance as Israel-Iran crisis escalates
Asian shares are mixed and oil prices advance as Israel-Iran crisis escalates

Yahoo

time34 minutes ago

  • Yahoo

Asian shares are mixed and oil prices advance as Israel-Iran crisis escalates

HONG KONG (AP) — Asian shares were mixed on Monday and oil prices extended gains on worries that escalating Iran-Israel tensions could disrupt the flow of crude around the world. U.S. benchmark crude oil added 20 cents to $73.18 per barrel. Brent crude, the international standard, gained 95 cents to $75.18 per barrel. In share trading, Tokyo's Nikkei 225 added 1.3% to 38,307.74, while the Kospi in Seoul gained 0.9% to 2,920.57. Chinese markets were little changed after data for May showed stronger consumer spending but weaker factory activity and investment. A 6.1% year-on-year jump in retail sales was offset but lower than expected growth in industrial output, which rose 5.8% from a year earlier. Hong Kong's Hang Seng fell 0.1% to 23,864.20 and the Shanghai Composite Index added less than 0.1% to 3,378.78. Australia's S&P/ASX 200 fell 0.2% to 8,547.40. On Friday, oil prices jumped and stocks slumped after Israel's attack on Iranian nuclear and military targets. The S&P 500 sank 1.1% to 5,976.97. The Dow Jones Industrial Average dropped 1.8% to 42,197.79, and the Nasdaq composite lost 1.3% to 19,406.83. The strongest action was in the oil market, where the price of a barrel of benchmark U.S. crude and Brent crude, the international standard surged more than 7%. Iran is one of the world's major producers of oil, though sanctions by Western countries have limited its sales. If a wider war erupts, it could slow the flow of Iran's oil to its customers and keep the price of crude and gasoline higher for everyone worldwide. Beyond the oil coming from Iran, analysts also pointed to the potential for disruptions in the Strait of Hormuz, a relatively narrow waterway off Iran's coast. Much of the world's oil that's been pulled from the ground moves through it on ships. Companies that use a lot of fuel as part of their business and need their customers feeling confident enough to travel suffered some of the sharpest losses. Cruise operator Carnival dropped 4.9%. United Airlines sank 4.4%, and Norwegian Cruise Line Holdings fell 5%. They helped overshadow gains for U.S. oil producers and other companies that could benefit from increased fighting between Israel and Iran. Exxon Mobil rose 2.2%, and ConocoPhillips gained 2.4% because the leaping price of crude portends bigger profits for them. Contractors that make weapons and defense equipment also rallied. Lockheed Martin, Northrop Grumman and RTX all rose more than 3%. The price of gold climbed as investors searched for safer places to park their cash. An ounce of gold added 1.4% on Friday and was holding steady early Monday. Prices for Treasury bonds will likewise rise when investors are feeling nervous, but Treasury prices fell Friday, which in turn pushed up their yields, in part because of worries that a spike in oil prices could drive inflation higher. Inflation has remained relatively tame recently, and it's near the Federal Reserve's target of 2%, but worries are high that it could be set to accelerate because of President Donald Trump's tariffs. A better-than-expected report Friday on sentiment among U.S. consumers also helped drive yields higher. The preliminary report from the University of Michigan said sentiment improved for the first time in six months after Trump put many of his tariffs on pause, while U.S. consumers' expectations for coming inflation eased. On Wall Street, Adobe fell 5.3% even though the company behind Photoshop reported a stronger profit for the latest quarter than Wall Street expected. Analysts called it a solid performance but said investors may have been looking for some bigger revenue forecasts for the upcoming year. In currency trading early Monday, the U.S. dollar gained to 144.37 Japanese yen from 144.03 yen. The euro rose to $1.1537 from $1.1533. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store